These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38763674)

  • 21. Development of Water-Triggered Chitosan Film Containing Glucamylase for Sustained Release of Resveratrol.
    Zhang D; Cao Y; Ma C; Chen S; Li H
    J Agric Food Chem; 2017 Mar; 65(12):2503-2512. PubMed ID: 28198191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New chromatographic insights on drug:cyclodextrin inclusion complexes and their potential use in drug delivery.
    Constantin M; Cosman B; Ascenzi P; Simionescu BC; Fundueanu G
    Expert Opin Drug Deliv; 2022 Dec; 19(12):1696-1709. PubMed ID: 36372064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slow-release characteristics of diltiazem from ethylated beta-cyclodextrin complexes.
    Horiuchi Y; Hirayama F; Uekama K
    J Pharm Sci; 1990 Feb; 79(2):128-32. PubMed ID: 2324960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of freeze-dried gallic acid/xyloglucan.
    Hirun N; Sangfai T; Tantishaiyakul V
    Drug Dev Ind Pharm; 2015 Feb; 41(2):194-200. PubMed ID: 24229065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained release of flufenamic acid from a drug-triacetyl-beta-cyclodextrin complex.
    Nakanishi K; Masukawa T; Nadai T; Yoshii K; Okada S; Miyajima K
    Biol Pharm Bull; 1997 Jan; 20(1):66-70. PubMed ID: 9013809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro plasma hydrolysis of phenolic esters and their absorption kinetics in rats: Controlled release of phenolic compounds and enhanced health benefits.
    Wang X; Wang Q; Cai D; Yu J; Liu X; Yin F; Zhou D
    Food Chem; 2024 Mar; 435():137647. PubMed ID: 37804730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation, release and physicochemical characterisation of ethyl butyrate and hexanal inclusion complexes with β- and γ-cyclodextrin.
    Zhang Y; Zhou Y; Cao S; Li S; Jin S; Zhang S
    J Microencapsul; 2015; 32(7):711-8. PubMed ID: 26471403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies.
    Mendes C; Buttchevitz A; Kruger JH; Kratz JM; Simões CM; de Oliveira Benedet P; Oliveira PR; Silva MA
    Eur J Pharm Sci; 2016 Feb; 83():71-8. PubMed ID: 26687444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and in vitro, in vivo characterization of elastic liposomes encapsulating cyclodextrin-colchicine complexes for topical delivery of colchicine.
    Singh HP; Tiwary AK; Jain S
    Yakugaku Zasshi; 2010 Mar; 130(3):397-407. PubMed ID: 20190524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid-state flurbiprofen and methyl-β-cyclodextrin inclusion complexes prepared using a single-step, organic solvent-free supercritical fluid process.
    Rudrangi SR; Kaialy W; Ghori MU; Trivedi V; Snowden MJ; Alexander BD
    Eur J Pharm Biopharm; 2016 Jul; 104():164-70. PubMed ID: 27163245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique.
    Bourkaib N; Zhou J; Yao J; Fang Z; Mezghrani O
    Drug Dev Ind Pharm; 2013 Jun; 39(6):918-27. PubMed ID: 22998295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits.
    Fernandes CM; Ramos P; Falcão AC; Veiga FJ
    J Control Release; 2003 Feb; 88(1):127-34. PubMed ID: 12586510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
    Fernandes CM; Teresa Vieira M; Veiga FJ
    Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
    Holvoet C; Plaizier-Vercammen J; Vander Heyden Y; Gabriëls M; Camu F
    Int J Pharm; 2003 Oct; 265(1-2):13-26. PubMed ID: 14522114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
    Yurtdaş-Kırımlıoğlu G
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
    Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and characterization of amiodarone-methyl-beta-cyclodextrin inclusion complexes: A molecular modelling perspective.
    Rubim AM; Rubenick JB; Vendrame LO; Zanella I; Rolim CMB; Rhoden CRB
    J Mol Graph Model; 2024 Jan; 126():108639. PubMed ID: 37774479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.
    Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M
    J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.